Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients

Mise à jour : Il y a 4 ans
Référence : NCT00319189

Femme et Homme

  • | Pays :
  • Norway
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The objective of the present study is to evaluate both the efficacy and safet of nateglinide in renal transplanta recipients with posttransplant diabetes mellitus or impaired glucose tolerance. Primarily will the change in glucose tolerance and acute insuline responce be addressed.


Critère d'inclusion

  • Renal Transplant Recipients ,Posttransplant Diabetes Mellitus ,Posttransplant Impaired Glucose Tolerance

Liens